DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

DIGITAL CONTENT

15 NEWS #PharmaBuzz

media
15 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

11DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1092977-61-1, 2-((3-butoxyphenethyl)amino)-n,n-dimethylacetamide, Evenamide [inn], Nw-3509, On5s6n53js, Mfcd28502433

Molecular Formula

C₁₆H₂₆N₂O₂

Molecular Weight

278.39 g/mol

InChI Key

GRHBODILPPXVKN-UHFFFAOYSA-N

FDA UNII

ON5S6N53JS

1 2D Structure

Evenamide

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[2-(3-butoxyphenyl)ethylamino]-N,N-dimethylacetamide

2.1.2 InChI

InChI=1S/C16H26N2O2/c1-4-5-11-20-15-8-6-7-14(12-15)9-10-17-13-16(19)18(2)3/h6-8,12,17H,4-5,9-11,13H2,1-3H3

2.1.3 InChI Key

GRHBODILPPXVKN-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCCCOC1=CC=CC(=C1)CCNCC(=O)N(C)C

2.2 Other Identifiers

2.2.1 UNII

ON5S6N53JS

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 1092977-61-1

2. 2-((3-butoxyphenethyl)amino)-n,n-dimethylacetamide

3. Evenamide [inn]

4. Nw-3509

5. On5s6n53js

6. Mfcd28502433

7. 2-((2-(3-butoxyphenyl)ethyl)amino)-n,n-dimethylacetamide

8. Acetamide, 2-((2-(3-butoxyphenyl)ethyl)amino)-n,n-dimethyl-

9. 2-[(3-butoxyphenethyl)amino]-n,n-dimethylacetamide

10. Unii-on5s6n53js

11. Evenamid

12. Evenamide [who-dd]

13. Schembl3025285

14. Chembl3678076

15. Bdbm161090

16. Dtxsid101032897

17. Sb18910

18. Ac-35786

19. As-48527

20. Hy-17612

21. Sy244487

22. Cs-0014697

23. F50592

24. Q21098995

25. 2-[2-(3-butoxyphenyl)ethylamino]-n,n-dimethylacetamide

26. Us9051240, 2-[2-(3-butoxyphenyl)-ethylamino]-n,n-dimethylacetamide

2.4 Create Date

2008-12-22

3 Chemical and Physical Properties

Molecular Formula	C₁₆H₂₆N₂O₂
Molecular Weight	278.39 g/mol
XLogP3	2.5
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	9
Exact Mass	278.199428076 g/mol
Monoisotopic Mass	278.199428076 g/mol
Topological Polar Surface Area	41.6 Å²
Heavy Atom Count	20
Formal Charge	0
Complexity	269
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1